BioWorld - Tuesday, August 4, 2026

BioWorld Science

Aug. 26, 2021

View Archived Issues

Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer

Read More

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Read More

New Toll-like receptor 7 agonists identified at Bristol Myers Squibb

Read More

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

Read More

New CREB-2 inhibitors discovered at Evotec International

Read More

Memorial Sloan-Kettering Cancer Center describes prodrugs useful in adoptive cell therapy

Read More

Mutational profiling gives clues to development, new puzzles about disease

Read More

Blade receives IND clearance for phase I study of cudetaxestat for IPF

Read More

Data presented for Almirall's JAK inhibitor LAS-200019

Read More

Janssen targets DHODH with new compounds for acute myelogenous leukemia

Read More

HUTCHMED begins phase Ib/II study of fruquintinib with tislelizumab in TNBC and endometrial cancer

Read More

New phase I/II trial investigates RVU-120 in relapsed/refractory metastatic or advanced solid tumors

Read More

CPI-613 advances into phase II evaluation in biliary tract cancer

Read More

Phase II trial of izokibep in ankylosing spondylitis commences dosing

Read More

Epeleuton shows promise in hamster model for SARS-CoV-2 infection

Read More

Mutation in RAPGEF1 gene tied to global developmental delay syndrome

Read More

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Read More

Studies reveal efficacy and mechanism of SARS-CoV-2-neutralizing antibody SC-31

Read More